These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 21276817)

  • 41. Organization and dynamics of the actin cytoskeleton during dendritic spine morphological remodeling.
    Chazeau A; Giannone G
    Cell Mol Life Sci; 2016 Aug; 73(16):3053-73. PubMed ID: 27105623
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Deficits in synaptic function occur at medial perforant path-dentate granule cell synapses prior to Schaffer collateral-CA1 pyramidal cell synapses in the novel TgF344-Alzheimer's Disease Rat Model.
    Smith LA; McMahon LL
    Neurobiol Dis; 2018 Feb; 110():166-179. PubMed ID: 29199135
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Thin, stubby or mushroom: spine pathology in Alzheimer's disease.
    Tackenberg C; Ghori A; Brandt R
    Curr Alzheimer Res; 2009 Jun; 6(3):261-8. PubMed ID: 19519307
    [TBL] [Abstract][Full Text] [Related]  

  • 44. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
    Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
    Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transmitting on actin: synaptic control of dendritic architecture.
    Schubert V; Dotti CG
    J Cell Sci; 2007 Jan; 120(Pt 2):205-12. PubMed ID: 17215449
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of synaptojanin 1 ameliorates synaptic and behavioral impairments in a mouse model of Alzheimer's disease.
    McIntire LB; Berman DE; Myaeng J; Staniszewski A; Arancio O; Di Paolo G; Kim TW
    J Neurosci; 2012 Oct; 32(44):15271-6. PubMed ID: 23115165
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dendritic spine actin cytoskeleton in autism spectrum disorder.
    Joensuu M; Lanoue V; Hotulainen P
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Jun; 84(Pt B):362-381. PubMed ID: 28870634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SPG302 Reverses Synaptic and Cognitive Deficits Without Altering Amyloid or Tau Pathology in a Transgenic Model of Alzheimer's Disease.
    Trujillo-Estrada L; Vanderklish PW; Nguyen MMT; Kuang RR; Nguyen C; Huynh E; da Cunha C; Javonillo DI; Forner S; Martini AC; Sarraf ST; Simmon VF; Baglietto-Vargas D; LaFerla FM
    Neurotherapeutics; 2021 Oct; 18(4):2468-2483. PubMed ID: 34738197
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synaptic targeting by Alzheimer's-related amyloid beta oligomers.
    Lacor PN; Buniel MC; Chang L; Fernandez SJ; Gong Y; Viola KL; Lambert MP; Velasco PT; Bigio EH; Finch CE; Krafft GA; Klein WL
    J Neurosci; 2004 Nov; 24(45):10191-200. PubMed ID: 15537891
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Thrombospondin-1 prevents amyloid beta-mediated synaptic pathology in Alzheimer's disease.
    Son SM; Nam DW; Cha MY; Kim KH; Byun J; Ryu H; Mook-Jung I
    Neurobiol Aging; 2015 Dec; 36(12):3214-3227. PubMed ID: 26452999
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Synaptic dysfunction and disruption of postsynaptic drebrin-actin complex: a study of neurological disorders accompanied by cognitive deficits.
    Kojima N; Shirao T
    Neurosci Res; 2007 May; 58(1):1-5. PubMed ID: 17379343
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Linking amyloid-β and tau: amyloid-β induced synaptic dysfunction via local wreckage of the neuronal cytoskeleton.
    Zempel H; Mandelkow EM
    Neurodegener Dis; 2012; 10(1-4):64-72. PubMed ID: 22156588
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of pathological tau in synaptic dysfunction in Alzheimer's diseases.
    Wu M; Zhang M; Yin X; Chen K; Hu Z; Zhou Q; Cao X; Chen Z; Liu D
    Transl Neurodegener; 2021 Nov; 10(1):45. PubMed ID: 34753506
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Why Alzheimer's is a disease of memory: the attack on synapses by A beta oligomers (ADDLs).
    Viola KL; Velasco PT; Klein WL
    J Nutr Health Aging; 2008 Jan; 12(1):51S-7S. PubMed ID: 18165846
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Alzheimer's disease-like pathology induced by amyloid-β oligomers in nonhuman primates.
    Forny-Germano L; Lyra e Silva NM; Batista AF; Brito-Moreira J; Gralle M; Boehnke SE; Coe BC; Lablans A; Marques SA; Martinez AM; Klein WL; Houzel JC; Ferreira ST; Munoz DP; De Felice FG
    J Neurosci; 2014 Oct; 34(41):13629-43. PubMed ID: 25297091
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The structure and function of actin cytoskeleton in mature glutamatergic dendritic spines.
    Bellot A; Guivernau B; Tajes M; Bosch-Morató M; Valls-Comamala V; Muñoz FJ
    Brain Res; 2014 Jul; 1573():1-16. PubMed ID: 24854120
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dendritic spine actin dynamics in neuronal maturation and synaptic plasticity.
    Hlushchenko I; Koskinen M; Hotulainen P
    Cytoskeleton (Hoboken); 2016 Sep; 73(9):435-41. PubMed ID: 26849484
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC; Weinstein D; Monasterio O; Inestrosa NC
    Biochemistry; 2011 Sep; 50(38):8127-37. PubMed ID: 21838267
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Actin Tyrosine-53-Phosphorylation in Neuronal Maturation and Synaptic Plasticity.
    Bertling E; Englund J; Minkeviciene R; Koskinen M; Segerstråle M; Castrén E; Taira T; Hotulainen P
    J Neurosci; 2016 May; 36(19):5299-313. PubMed ID: 27170127
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Amyloid-beta-induced neuronal dysfunction in Alzheimer's disease: from synapses toward neural networks.
    Palop JJ; Mucke L
    Nat Neurosci; 2010 Jul; 13(7):812-8. PubMed ID: 20581818
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.